LexisNexis Reed Tech Expands Portfolio, Now Offers eCTD Services
Solution includes assistance with submitting regulatory submissions.
LexisNexis Reed Tech, a provider of regulatory submissions, data management, and analytics solutions for the life sciences industry, is expanding its services portfolio to offer end-to-end electronic common technical document (eCTD) solutions and services to support manufacturers, distributors, and related operations. The eCTD service expansion, says Reed Tech, provides a solution for compiling, formatting, and submitting regulatory submissions in electronic, compliant format.
The company will support pharma companies, contract research organizations (CROs), and other stakeholders in preparing regulatory submissions, including investigational new drug application (IND), new drug application (NDA), abbreviated new drug applications (ANDA), biologics license application (BLA), and more.
"Our goal is to simplify the regulatory submission process for our clients by providing expert eCTD submission publishing services that ensure compliance, accuracy, and timeliness,” notes Wendy Scott, head of life sciences professional services at Reed Tech. " … This new service will offer a more complete regulatory solution for our 1,000+ current SPL pharma customers, as well as potential new customers, in one place, increasing efficiency while managing the product regulatory approval process."
LogiPharma Unpacked: Highlights, Key Insights, and the Road to 2025
October 16th 2024In this special post-show episode, we sit down with Ryan Portela, Head of Production for LogiPharma, to reflect on the highlights and key takeaways from this year’s event. From attendee feedback to the most impactful sessions, Ryan shares insider insights and discusses how the momentum from 2024 will continue to shape the future of pharma supply chains. Plus, get a sneak peek into the exciting plans for LogiPharma's 20th Anniversary in 2025.
Reimagining Closed-Loop Marketing Strategies for Pharma Companies
November 21st 2024The pharmaceutical industry is evolving, and so are the strategies needed to connect with healthcare professionals. Closed-loop marketing (CLM) has become essential in delivering personalized, data-driven engagement that resonates with physicians and improves key outcomes, such as enhancing patient care, increasing
Maximize Pharma’s Potential with AI-Ready Data for Commercial Excellence
November 21st 2024As the pharmaceutical industry embraces the power of AI, having data that’s large, diverse, and well-structured is critical for driving innovation and improving outcomes. Ensuring your data is AI-ready and can be used with more advanced solutions enables your teams to make informed strategic decisions, predict trends, enhance customer engagements and drive overall strategy.
